AC Immune S.A. (ACIU) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 8 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for ACIU is $7.00, representing a +122.9% upside from the current price of $3.14. Price targets range from a low of $7.00 to a high of $7.00.
